E. Stolz et al., Screening for thrombophilic risk factors among 25 German patients with cerebral venous thrombosis, ACT NEUR SC, 102(1), 2000, pp. 31-36
Objectives - In this study the frequency of inherited thrombophilic risk fa
ctors in a population of German CVT patients and their influence on clinica
l outcome were evaluated. Material and methods - Twenty-five patients (age
37.1 +/- 16.3 years) with CVT were screened for inherited coagulation disor
ders. All participants received a full clinical follow-up (mean follow-up p
eriod 4.8 +/- 6.4 years). Results - Inherited thrombophilic risk factors we
re identified in 9 (36%) of the 25 patients studied. Four were found positi
ve for the heterozygous factor V Leiden mutation, 2 were heterozygous carri
ers of the prothrombin-G20210A-polymorphism. APC resistance proved to be a
reliable screening method for factor V Leiden mutation, whereas genetic eva
luation for protein S and C deficiencies failed to demonstrate any mutation
s despite the identification of 1 patient with a protein C and protein S de
ficiency each. One patient suffered from a familial plasminogen deficiency.
These 9 patients had a less favorable outcome (P < 0.05). Conclusion - Our
results demonstrate that screening for inherited thrombophilia should be a
n integral part in the diagnostic work up of CVT patients. Patients with in
herited coagulopathies tended to have a less favorable outcome, corroborati
ng recommendations for a longer period of oral anticoagulation.